Posted on June 9th, 2026
Exercise physiologist Dr Stephanie Frade shared practical strategies for people with scleroderma to move safely and confidently, addressing common barriers like fatigue and joint stiffness.
Posted on May 2nd, 2026
A new study published in The Lancet Rheumatology found genetic links to systemic sclerosis may differ by sex, which could help explain why women are more commonly affected but men often have a more severe disease course.
Continue reading genetic links to systemic sclerosis may differ by sex, new study finds
Posted on April 23rd, 2026
A 17-year-old boy with severe scleroderma showed “dramatic” improvement after undergoing autologous stem cell transplant (ASCT), which may represent an important therapeutic option for patients who develop the disease at a young age.
Continue reading stem cell transplant safely eases scleroderma symptoms for teen
Posted on April 23rd, 2026
A Turkish study found that elevated levels of the liver enzyme alanine aminotransferase (ALT) can help diagnose autoimmune hepatitis in people with systemic sclerosis.
Continue reading liver enzyme levels help diagnose autoimmune hepatitis in ssc: study
Posted on March 28th, 2026
Researchers at Aisa Pharma found that treatment with their drug AISA-021 safely reduced Raynaud’s attack duration and eased symptoms in people with systemic sclerosis (SSc).
Continue reading new ssc drug safely cuts raynaud’s attack duration, eases symptoms
Posted on March 28th, 2026
A study published in ACR Open Rheumatology found that measuring anti-CD146 antibodies may help identify people with systemic sclerosis (SSc) whose disease is associated with occupational exposure to silica and other mineral dusts.
Continue reading anti-cd146 antibodies may signal occupational exposure in ssc: study
Posted on March 28th, 2026
Scientists have identified 89 existing medications that could potentially be repurposed as treatments for scleroderma through an analysis of genetic data.
Continue reading new study flags existing medications as possible scleroderma treatments
Posted on March 9th, 2026
A German clinical trial found that carbon dioxide hand baths can significantly widen blood vessels of fingers in people with systemic sclerosis (SSc)-associated Raynaud’s phenomenon, potentially easing symptoms.
Continue reading carbon dioxide hand baths may help in ssc-related raynaud’s, study finds
Posted on March 3rd, 2026
A new study finds that more patients with SSc-ILD are receiving early treatment, with immunosuppressive and combination treatments increasing significantly over two decades, leading to declining ILD progression rates but still a suboptimal prognosis for those affected.
Continue reading more ssc-ild patients receive early treatment, new study finds
Posted on February 24th, 2026
A study published in Arthritis Research & Therapy found elevated soluble CD13 levels in patients with scleroderma but no clear correlation with disease severity or specific clinical features.
Continue reading cd13 levels elevated in scleroderma, but biomarker value unclear